Nguyen TL Wolfensberger TJ 2019 PURPOSE To characterise the surgical removal technique of a dislocated dexamethasone implant in the anterior chamber and to gauge its success by analysing corneal transparency and subsequent visual acuity recovery in the postoperative phase. METHODS Description of a patient who presented with an anterior chamber dexamethasone implant migration through an inferior iridotomy performed previously for a silicone oil fill in aphakia. Visual acuity had dropped to counting fingers due to marked corneal oedema. RESULTS The implant was removed using a 23-g needle aligned with the axis of the implant through a paracentesis. After the clinical follow-up at 2 months, best-corrected visual acuity had returned to 0.2, which remained stable at the last follow-up at 14 months with an intraocular pressure of 10 mmHg. The corneal oedema resolved completely. CONCLUSION This novel surgical management of a dexamethasone implant dislocation into the anterior chamber was successful and resulted in no long-term corneal damage when the implant was removed without delay. A repeated Ozurdex injection in patients with previous inferior iridotomy may require prior suturing of the iridotomy. https://sonar.ch/global/documents/78298 eng info:eu-repo/semantics/altIdentifier/doi/10.1055/a-0808-1847 info:eu-repo/semantics/altIdentifier/pmid/30616285 Klinische Monatsblatter fur Augenheilkunde. - 2019 Anterior Chamber Dexamethasone Drug Implants Foreign-Body Migration Humans Macular Edema Management of Anterior Chamber Dislocation of a Dexamethasone Implant. http://purl.org/coar/resource_type/c_6501